| Financial Year |
March 31 2023 |
| Monetary Funds |
1,063,346,600.20 |
| Held-for-trading Financial Assets |
95,734,260.34 |
| Notes Receivable |
28,600,000.00 |
| Accounts Receivable |
82,800,470.07 |
| Advances to Suppliers |
16,375,762.68 |
| Other Receivables |
86,209,133.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
50,118,308.04 |
| Inventories |
35,334,778.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,266,635.31 |
| Other Current Assets |
9,202,110.08 |
| Total Current Assets |
1,418,869,750.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,955,002.70 |
| Long-term Equity Investment |
531,529,098.17 |
| Investment Properties |
-- |
| Fixed Assetes |
396,903,679.66 |
| Under-construction Projects |
32,619,262.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
98,388,982.17 |
| R&D expenses |
-- |
| Goodwill |
251,538,486.36 |
| Long-Term Deferred and Prepaid Expenses |
674,619.12 |
| Deferred Income Tax Assets |
16,149,859.93 |
| Other Non-Current Assets |
122,598,621.15 |
| Sub-Total of Non-Current Assets |
2,038,785,738.18 |
| Total Assets |
3,457,655,488.69 |
| Short-Term Loans |
63,597,918.52 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
58,003,017.06 |
| Accounts Received In Advance |
351,414.68 |
| Employee Compensation Payable |
5,265,745.44 |
| Taxes Payable |
30,670,304.84 |
| Interest Payable |
-- |
| Dividend Payable |
1,115,000.00 |
| Other payables |
6,132,832.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
40,151,562.16 |
| Other Current Liabilities |
736,283.22 |
| Sub-Total of Current Liabilities |
225,564,919.86 |
| Long-term Loans |
24,100,364.79 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
11,938,498.22 |
| Special Payable |
-- |
| Estimatied Liabilities |
164,000,000.00 |
| Deferred Income Tax Liabilities |
87,800,104.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
300,144,779.29 |
| Total Liabilities |
525,709,699.15 |
| Paid-In Capital(Or Share Stock) |
844,194,741.00 |
| Capital Surplus |
22,250,103.80 |
| Surplus Reserve |
384,958,693.24 |
| LESS:Treasury Stock |
129,973,471.21 |
| Undistributed Profits |
1,783,542,889.44 |
| Minority Stockholder's Interest |
26,957,697.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,904,988,091.79 |
| Owner's Equity（Stockholder's Equity） |
2,931,945,789.54 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,457,655,488.69 |
